Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David G Huntsman

Showing results (41-50 of 320) with videos related to

Pageof 32
Sort By:
The Journal of Pathology|May 14, 2004
Model of the early development of diffuse gastric cancer in E-cadherin mutation carriers and its implications for patient screeningFátima Carneiro, David G Huntsman, Thomas C Smyrk, et al.
The American Journal of Surgical Pathology|August 13, 2011
Frequency of known gene rearrangements in endometrial stromal tumorsSarah Chiang, Rola Ali, Nataliya Melnyk, et al.
Scientific Reports|October 8, 2016
Quantitative Profiling of Single Formalin Fixed Tumour Sections: proteomics for translational researchChristopher S Hughes, Melissa K McConechy, Dawn R Cochrane, et al.
The American Journal of Surgical Pathology|January 13, 2015
FOXL2 mutation is absent in uterine tumors resembling ovarian sex cord tumorsSarah Chiang, Paul N Staats, Janine Senz, et al.
Cancer|March 17, 2005
Coexpression of the type 1 growth factor receptor family members HER-1, HER-2, and HER-3 has a synergistic negative prognostic effect on breast carcinoma survivalSam M Wiseman, Nikita Makretsov, Torsten O Nielsen, et al.
Anticancer Research|January 25, 2008
Expression of integrin-linked kinase is not a useful prognostic marker in resected hepatocellular cancerPongphob Intaraprasong, Kiran Assi, David A Owen, et al.
Obstetrics and Gynecology|July 11, 2012
Germline BRCA1 and BRCA2 mutations in ovarian cancer: utility of a histology-based referral strategyKasmintan A Schrader, Jane Hurlburt, Steve E Kalloger, et al.
Nature|December 18, 2009
Identification of sister chromatids by DNA template strand sequencesEster Falconer, Elizabeth A Chavez, Alexander Henderson, et al.
BMC Cancer|May 3, 2026
Co-targeting cystathionine gamma-lyase and mTOR: a promising therapeutic strategy in clear cell ovarian cancerLongyijie Wei, Amal M El-Naggar, Yuqin Li, et al.
The Journal of Pathology. Clinical Research|June 17, 2021
STING pathway expression in low-grade serous carcinoma of the ovary: an unexpected therapeutic opportunity?Jutta Huvila, Dawn R Cochrane, Monica Ta, et al.
Pageof 32

Showing results (41-50 of 320) with videos related to

Sort By:
Pageof 32
The Journal of Pathology|May 14, 2004
Model of the early development of diffuse gastric cancer in E-cadherin mutation carriers and its implications for patient screeningFátima Carneiro, David G Huntsman, Thomas C Smyrk, et al.
The American Journal of Surgical Pathology|August 13, 2011
Frequency of known gene rearrangements in endometrial stromal tumorsSarah Chiang, Rola Ali, Nataliya Melnyk, et al.
Scientific Reports|October 8, 2016
Quantitative Profiling of Single Formalin Fixed Tumour Sections: proteomics for translational researchChristopher S Hughes, Melissa K McConechy, Dawn R Cochrane, et al.
The American Journal of Surgical Pathology|January 13, 2015
FOXL2 mutation is absent in uterine tumors resembling ovarian sex cord tumorsSarah Chiang, Paul N Staats, Janine Senz, et al.
Cancer|March 17, 2005
Coexpression of the type 1 growth factor receptor family members HER-1, HER-2, and HER-3 has a synergistic negative prognostic effect on breast carcinoma survivalSam M Wiseman, Nikita Makretsov, Torsten O Nielsen, et al.
Anticancer Research|January 25, 2008
Expression of integrin-linked kinase is not a useful prognostic marker in resected hepatocellular cancerPongphob Intaraprasong, Kiran Assi, David A Owen, et al.
Obstetrics and Gynecology|July 11, 2012
Germline BRCA1 and BRCA2 mutations in ovarian cancer: utility of a histology-based referral strategyKasmintan A Schrader, Jane Hurlburt, Steve E Kalloger, et al.
Nature|December 18, 2009
Identification of sister chromatids by DNA template strand sequencesEster Falconer, Elizabeth A Chavez, Alexander Henderson, et al.
BMC Cancer|May 3, 2026
Co-targeting cystathionine gamma-lyase and mTOR: a promising therapeutic strategy in clear cell ovarian cancerLongyijie Wei, Amal M El-Naggar, Yuqin Li, et al.
The Journal of Pathology. Clinical Research|June 17, 2021
STING pathway expression in low-grade serous carcinoma of the ovary: an unexpected therapeutic opportunity?Jutta Huvila, Dawn R Cochrane, Monica Ta, et al.
Pageof 32